z-logo
Premium
Sinonasal cancer in The Netherlands: Follow‐up of a population‐based study 1989‐2014 and incidence of occupation‐related adenocarcinoma
Author(s) -
Kuijpens J. Hans L. P.,
Louwman Marieke W. J.,
Takes Robert,
Slootweg Piet J.,
Burdorf Alex,
van Dijk Boukje A. C.
Publication year - 2018
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.25374
Subject(s) - medicine , adenocarcinoma , incidence (geometry) , cancer , cancer registry , confidence interval , population , nasal cavity , surgery , environmental health , physics , optics
Background Long‐term trends of sinonasal cancer in The Netherlands have been investigated with particular attention on adenocarcinoma for which wood or leather dust is a well‐known risk factor. Methods All 4345 patients (1989‐2014) registered in the Netherlands Cancer Registry were included. Standardized 3‐year moving incidence rates per 1 000 000/person‐years, and estimated annual percentage change (EAPC) were calculated. Results Forty‐seven percent of the patients had squamous cell carcinoma (SCC), 12% had lymphoma, and 12% had adenocarcinoma. Sixty‐one percent of the tumors were located in the nasal cavity, 22% in the maxillary, and 11% in the ethmoidal sinus. Male incidence decreased to 11.5/1 000 000 due to less SCC (EAPC −0.9%; 95% confidence interval [CI] −1.6 to 0.3) and adenocarcinoma (EAPC −4.3%; 95% CI −5.5 to 3.1). Female incidence increased to 7/1 000 000 (EAPC +2.0%; 95% CI +1.1 to +3.0) due to more SCC (EAPC +2.2%; 95% CI +1.0 to +3.5), whereas adenocarcinoma remained stable (0.6/1 000 000; EAPC +1.1%; 95% CI −6.0 to +8.7). Tumors of the nasal cavity increased in women (EAPC +3.3%; 95% CI +2.0 to 4.7). Conclusion The decrease of male sinonasal adenocarcinoma may be the result of preventive measures combined with less workers in high‐risk occupations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here